Schedule 13G ownership disclosure
CoLucid Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 19716T101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,245,902
- Percent of class
- 14.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-16-000873
- Form type
- SC 13G
- Filer
- CoLucid Pharmaceuticals, Inc.
- CIK
- CIK 1348649
- Filed
- Jan 19, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership